Thrivent Financial for Lutherans
AVXL icon

Thrivent Financial for Lutherans’s Anavex Life Sciences AVXL Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,903
Closed -$59K – 2524
2020
Q4 		$59K Sell
10,903
-37,171
-77% -$196K ﹤0.01% 2448
2020
Q3 		$219K Sell
48,074
-29,470
-38% -$127K ﹤0.01% 2271
2020
Q2 		$382K Hold
77,544
– – ﹤0.01% 2024
2020
Q1 		$244K Buy
+77,544
New +$270K ﹤0.01% 2056

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return